aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Zoetis Inc., founded in 1952 and headquartered in Parsippany, New Jersey, is a leading global animal health company. The company's mission is to nurture the world by advancing animal care, which is vital for the comfort, companionship, and nutrition that people derive from animals. Zoetis develops, manufactures, and commercializes a wide range of animal health products, including medicines, vaccines, diagnostic products, parasiticides, and medicated feed additives. Their market focus spans both livestock (cattle, swine, poultry, fish, sheep) and companion animals (dogs, cats, horses).
Zoetis has achieved significant milestones, with a revenue of $8.54 billion and a net income of $2.34 billion in 2023. The company is publicly traded on the NYSE under the ticker ZTS and is a component of the S&P 500. Under the leadership of CEO Kristin Peck and Chair Michael McCallister, Zoetis has grown its global presence with approximately 14,100 employees worldwide. The company's commitment to animal health has made a substantial impact on the industry, enhancing the well-being of animals and supporting the needs of their owners.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Animal Health
Technology
Biotech
Tags
Biotech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
Who are Zoetis competitors?
Companies similar to Zoetis include Tropic, Torii, Cledara, CloudEagle, Bettercloud, and Vendr.com.
When was Zoetis founded?
Zoetis was founded in 1952.
Where is Zoetis’s headquarters located?
Zoetis’s headquarters is located in DE, US.
When was Zoetis’s last funding round?
Zoetis’s most recent funding round was for $15.3M (USD) in March 2023.
How many employees does Zoetis have?
Zoetis has 1430 employees as of Feb 6, 2024.
How much has Zoetis raised to-date?
As of July 05, 2023, Zoetis has raised a total of $27.3M (USD) since Mar 1, 2023.
Add Comparison
Total Raised to Date
$27.3M
USD
Last Update Mar 1, 2023
Last Deal Details
$15.3M
USD
Mar 1, 2023
Grant
Total Employees Over Time
1430
As of Feb 2024
Zoetis Address
Delaware
United States of America
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts